We are live on ! Find out more
PC

Promethos Capital Portfolio holdings

AUM $368M
1-Year Est. Return 27.67%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+27.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$283M
AUM Growth
+$2.63M
Cap. Flow
+$6.21M
Cap. Flow %
2.19%
Top 10 Hldgs %
47.87%
Holding
89
New
9
Increased
34
Reduced
3
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.61M
2
KMB icon
Kimberly-Clark
KMB
+$3.67M
3
GDDY icon
GoDaddy
GDDY
+$3.08M
4
NTAP icon
NetApp
NTAP
+$2.74M
5
STRL icon
Sterling Infrastructure
STRL
+$1.73M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.98M
2
AVGO icon
Broadcom
AVGO
+$5.41M
3
TGT icon
Target
TGT
+$4.33M
4
CIG icon
CEMIG Preferred Shares
CIG
+$563K
5
HSBC icon
HSBC
HSBC
+$116K

Sector Composition

Rank Sector Weight
1 Technology 37.11%
2 Financials 23.13%
3 Healthcare 14.43%
4 Industrials 7.99%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUS icon
76
ePlus
PLUS
$2.26B
$7.39K ﹤0.01%
100
TNC icon
77
Tennant Co
TNC
$1.16B
$5.71K ﹤0.01%
70
MAN icon
78
ManpowerGroup
MAN
$2.76B
$5.2K ﹤0.01%
90
NSA
79
DELISTED
National Storage Affiliates Trust
NSA
$4.55K ﹤0.01%
120
COLL icon
80
Collegium Pharmaceutical
COLL
$891M
$4.3K ﹤0.01%
150
HOUS
81
DELISTED
Anywhere Real Estate
HOUS
$1.81K ﹤0.01%
550
ABBV icon
82
AbbVie
ABBV
$470B
-30,278
Closed -$5.98M
AMN icon
83
AMN Healthcare
AMN
$1.37B
-200
Closed -$8.48K
AVGO icon
84
Broadcom
AVGO
$1.72T
-31,340
Closed -$5.41M
NSIT icon
85
Insight Enterprises
NSIT
$4.32B
-50
Closed -$10.8K
RGP icon
86
Resources Connection
RGP
$152M
-610
Closed -$5.92K
TGT icon
87
Target
TGT
$72.2B
-27,760
Closed -$4.33M

Similar funds

Promethos Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Promethos Capital held 89 positions worth $283M, up 0.94% from $281M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Promethos Capital's Q4 2024 filing shows 9 new, 34 increased, 3 reduced and 7 closed positions. Its largest new stake was Kimberly-Clark: 26,940 shares worth $3.53M. The largest sale was AbbVie, an estimated $5.98M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Promethos Capital's largest Q4 2024 buy was Kimberly-Clark: 26,940 shares worth $3.53M.
  • Promethos Capital added most to Bristol-Myers Squibb in Q4 2024, an estimated $4.61M increase.
  • Promethos Capital's biggest Q4 2024 reduction was CEMIG Preferred Shares, cutting an estimated $563K.
  • Promethos Capital fully exited AbbVie in Q4 2024, selling an estimated $5.98M.
  • Promethos Capital's ten largest holdings make up 48% of its $283M portfolio in Q4 2024.
  • Promethos Capital opened 9 new positions and closed 7 in Q4 2024.
  • Promethos Capital's portfolio value rose 0.94% quarter-over-quarter to $283M.

Based on Promethos Capital's 13F filing for Q4 2024, filed 13 Feb 2025.